title: Validation of short interfering RNA knockdowns by quantitative real-time PCR.
abstract: RNA interference (RNAi) is a natural mechanism, that is triggered by the introduction of double-stranded RNA into a cell. The long double-stranded RNA is then processed into short interfering RNA (siRNA) that mediates sequence-specific degradation of homologous transcripts. This phenomenon can be exploited to experimentally trigger RNAi and downregulate gene expression by transfecting mammalian cells with synthetic siRNA. Thus, siRNAs can be designed to specifically silence the expression of genes bearing a particular target sequence. In this chapter, we present methods and procedures for validating the effects of siRNA-based gene silencing on target gene expression. To illustrate our approach, we use examples from our analysis of a Cancer Gene Library of 278 siRNAs targeting 139 classic oncogenes and tumor suppressor genes (Qiagen Inc., Germantown, MD). Specifically, this library was used for high-throughput RNAi phenotype analysis followed by gene expression analysis to validate gene silencing for siRNA that produced a phenotype. Methods and protocols are presented that illustrate how sequence-specific gene silencing of effective siRNAs are analyzed and validated by quantitative real-time PCR assays to measure the extent of target gene silencing, as well as effects on various gene expression end points.
authors.affiliation: Pharmaceutical Genomics Division, Translational Genomics Institute, Scottsdale, AZ, USA.
authors.forename: Sukru
authors.initials: S
authors.lastname: Tuzmen
authors.forename: Jeff
authors.initials: J
authors.lastname: Kiefer
authors.forename: Spyro
authors.initials: S
authors.lastname: Mousses
mesh_terms: D001943:Breast Neoplasms / Q000235:genetics; D045744:Cell Line, Tumor; D018076:DNA, Complementary / Q000096:biosynthesis / Q000235:genetics; D004273:DNA, Neoplasm / Q000096:biosynthesis / Q000235:genetics; D005260:Female; D015870:Gene Expression; D016147:Genes, Tumor Suppressor; D006367:HeLa Cells; D006801:Humans; D009857:Oncogenes; D010641:Phenotype; D016133:Polymerase Chain Reaction / Q000379:methods* / Q000706:statistics & numerical data; D034622:RNA Interference; D012334:RNA, Neoplasm / Q000235:genetics / Q000302:isolation & purification; D034741:RNA, Small Interfering / Q000235:genetics*; D014162:Transfection
chemical_list: D018076:DNA, Complementary; D004273:DNA, Neoplasm; D012334:RNA, Neoplasm; D034741:RNA, Small Interfering